Close Menu
Home › Becton Dickinson Triplex STD Test Clears FDA Review

Becton Dickinson Triplex STD Test Clears FDA Review

Sep 14, 2016

NEW YORK (GenomeWeb) – A triplex test from Becton Dickinson to detect chlyamydia, gonorrhea, and trichomonas has been cleared by the US Food and Drug Administration, the company announced today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
23
Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
25
Featured Webinar

Cell-free DNA Testing for Fetal Aneuploidy: Lessons Learned and Implications for Clinical Practice

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

What's Popular?

In Molecular Diagnostics

  1. Eurofins Acquires Transplant Genomics

  2. FDNA, PerkinElmer Form Genetic Testing Technology Alliance

  3. Liquid Biopsy Monitoring, Surveillance Efforts Accelerate Across Cancer Types and Technologies

    Premium

  4. Liquid Biopsy Assay From MSKCC Approved by New York State

  5. At ASM Microbe, Stakeholders Discuss Reimbursement Issues for Multiplex Infectious Disease Tests

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.